Advertisement

Role of Antiarrhythmic Treatment in Dilated Cardiomyopathy

  • F. Furlanello
  • P. Dal Forno
  • G. Mosna
  • A. Bertoldi
  • R. Accardi
  • G. Inama
  • R. Bettini
  • G. Vergara
  • A. Valentini
Conference paper

Abstract

In recent years, there has been a growing interest in the problems of arrhythmias, particularly hyperkinetic ones, in dilated cardiomyopathy (DCM) patients, both from the point of view of incidence and of prognostic significance. In fact, DCM patients present not only a high prevalence of arrhythmias, but also a high rate of cardiac mortality.

Keywords

Sudden Death Sudden Cardiac Death Dilate Cardiomyopathy Cardiac Mortality Idiopathic Dilate Cardiomyopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Von Olshausen K, Stienen U, Schwartz F, Kübler W, Meyer J (1988) Long term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 61: 146–151PubMedCrossRefGoogle Scholar
  2. 2.
    Hofmann T, Meinertz T, Kaspar W, Geibel A, Zehender M, Hohnloser S, Stienen U, Tree N, Just H (1988) Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 116: 1455PubMedCrossRefGoogle Scholar
  3. 3.
    Romeo E, Pelliccia F, Cianfrocca C, Cristofani R, Reale A (1988) Identification of patients with idiopathic dilated cardiomyopathy at high risk of sudden cardiac death. Cardiostimolazione 6 (4): 249Google Scholar
  4. 4.
    Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152PubMedCrossRefGoogle Scholar
  5. 5.
    Stewart RAJ, Adams K, McKenna WJ, Oakley CM (1988) Prediction of sudden death in dilated cardiomyopathy. Eur Heart J 9 [Suppl 1]: 287Google Scholar
  6. 6.
    Neri R, Mestroni L, Salvi A, Pandullo C, Camerini F (1987) Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. Am Heart J 113: 707PubMedCrossRefGoogle Scholar
  7. 7.
    Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop R, Leitner V, Andersen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53: 902–907PubMedCrossRefGoogle Scholar
  8. 8.
    Von Olshausen K, Schäfer A, Meheml HC, Schwartz F, Senges J, Kübler W (1984) Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 51: 195CrossRefGoogle Scholar
  9. 9.
    Costanzo-Nordin MR, O’Connell JB, Engelmeier RS, Moran JF, Scanion PJ (1984) Ventricular tachycardia in dilated cardiomyopathy: a variable independent of hemodynamics, morphology and prognosis (abstr). J Am Coll Cardiol 3: 594Google Scholar
  10. 10.
    Meinertz T, Hofmann T, Zehender M, Geibel A, Kasper W, Just H (1988) Arrhythmias in dilated cardiomyopathy, In: Cosin J, Bayes de Luna AJ, Garcia Civera R, Cabades (eds) Cardiac arrhythmias. Pergamon, New York, pp 431–453Google Scholar
  11. 11.
    Von Olshausen K, Schäfer A, Meheml HC, Schwartz F, Senges J, Kübler W (1984) Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 51: 195–201CrossRefGoogle Scholar
  12. 12.
    Nobile A, Spampinato A, Nava S, Montenero S, Bellocci F (1988) Usefulness of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and non sustained ventricular tachycardia. Cardiostimolazione 6 (4): 247Google Scholar
  13. 13.
    Gössinger H, Siostrzonek P, Jung M, Grimm G, Schmoliner R, Mösslacher H (1988) Programmed ventricular stimulations in patients with dilated cardiomyopathy and non- sustained ventricular tachycardias. A follow-up study. Cardiostimolazione 6 (4): 249Google Scholar
  14. 14.
    Gonska BD, Bethge KP, Kreuzer H (1989) Can electrophysiologic studies predict sudden death in patients with idiopathic dilated cardiomyopathy? In: 4th European Symposium on Cardiac Pacing, Stockholm, 28–31 May 1989, abstract book, p 122Google Scholar
  15. 15.
    Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN (1987) Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Am J Cardiol 59: 291–295PubMedCrossRefGoogle Scholar
  16. 16.
    Naccarelli GV, Prystowsky EN, Jackman WM, Heger JJ, Rahilly GT, Zipes DP (1982) Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol 50: 165PubMedCrossRefGoogle Scholar
  17. 17.
    Poll DS, Marchinsky FE, Bucton AE, Doherty JU, Waxman HL, Josephson ME (1984) Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 70: 451PubMedCrossRefGoogle Scholar
  18. 18.
    Liem LB, Swerdlow CD (1988) Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 62: 611–616PubMedCrossRefGoogle Scholar
  19. 19.
    Borggrefe M, Egloff J, Budde T, Fetsch T, Karbenn U, Breithardt G (1988) Clinical value of late potentials as a marker of electrical instability in dilative cardiomyopathy. In: Santini M, Pistolese M, Alliegro A (eds) Progress in clinical pacing. Excerpta Medica, Amsterdam, p247Google Scholar
  20. 20.
    Almendral JM, Josephson ME (1988) An electrophysiological approach to drug therapy of ventricular arrhythmias. In: Bayes de Luna A, Betriu A, Permanyer G (eds) Therapeutics in cardiology. Kluwer, Dordrecht, pp 66–78Google Scholar
  21. 21.
    Bigger JT (1986) Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Coll Cardiol 57: 8BCrossRefGoogle Scholar
  22. 22.
    Brandenburg RO (1985) Cardiomyopathies and their role in sudden death. J Am Cardiol 5: 185B–189BCrossRefGoogle Scholar
  23. 23.
    Rapaport E (1988) Sudden cardiac death. Am J Cardiol 62: 31–61CrossRefGoogle Scholar
  24. 24.
    Furlanello F, Dal Forno P, Inama G, Accardi R, Bertoldi A, Bettini R, Guarnerio M, Valentini A, Vergara G (1988) Antiarrhythmic drug therapy in the prevention of post infarction sudden death. Results with amiodarone. In: Santini M, Pistoiese M, Alliegro A (eds) Progress in clinical pacing. Excerpta Medica, Amsterdam, p393Google Scholar
  25. 25.
    Furlanello F, Inama G, Dal Forno P, Padrini R, Piovan D, Pessina AC (1983) Amiodarone in the antiarrhythmic therapy. Pharmacol Res Commun 15: 881–890PubMedCrossRefGoogle Scholar
  26. 26.
    Inama G, Padrini R, Furlanello F (1984) Amiodarone antiarrhythmic treatment and blood level: methods of administration. In: Proceedings of the 6th International Congress of Cardiology. OIC Medial Press, Florence, pp 329–335Google Scholar
  27. 27.
    Furlanello F, Bettini R, Vergara G, Bertoldi A, Del Greco M, Durante GB, Frisanco L (1989) Marker and trigger mechanisms of sudden cardiac death. Exercise and sports activity. In: Bayes de Luna A (ed) Proceedings of sudden death. Barcelona (in press)Google Scholar
  28. 28.
    Borggrefe M, Trampisch HJ, Breithardt G (1988) Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias. J Am Coll Cardiol 112: 140–149CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • F. Furlanello
  • P. Dal Forno
  • G. Mosna
  • A. Bertoldi
  • R. Accardi
  • G. Inama
  • R. Bettini
  • G. Vergara
  • A. Valentini

There are no affiliations available

Personalised recommendations